PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
about
Data-driven integration of epidemiological and toxicological data to select candidate interacting genes and environmental factors in association with diseaseRegulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissueVanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activityEstrogen sulfotransferase/SULT1E1 promotes human adipogenesisInflammation, stress, and diabetesMammalian class Sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthasesPeroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiationGrowth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistanceFoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissueExpression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphologyCyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivationParallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgammaPharmacogenetic studies update in type 2 diabetes mellitusMesenchymal Stem Cells and Metabolic Syndrome: Current Understanding and Potential Clinical ImplicationsNuclear receptors and AMPK: can exercise mimetics cure diabetes?Mechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral SclerosisTreatment of prediabetesN-3 Polyunsaturated Fatty Acids and Inflammation in Obesity: Local Effect and Systemic BenefitPPAR-γ -- a possible drug target for complicated pregnanciesThe antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes.Ligand selectivity by seeking hydrophobicity in thyroid hormone receptorStructural Basis for Activation of Fatty Acid-binding Protein 4Structural evidence of the species-dependent albumin binding of the modified cyclic phosphatidic acid with cytotoxic propertiesCrystal structure of the ligand binding domain of the human nuclear receptor PPARgammaThe positive effects of yerba maté (Ilex paraguariensis) in obesityIdentification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobeThe non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesChronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolismDifferential regulation of expression of genes encoding uncoupling proteins 2 and 3 in brown adipose tissue during lactation in miceNovel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effectsPeroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell culturesMitochondrial function in vascular endothelial cell in diabetesPhytol/Phytanic acid and insulin resistance: potential role of phytanic acid proven by docking simulation and modulation of biochemical alterationsRegulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma functionThe novel gene fad158, having a transmembrane domain and leucine-rich repeat, stimulates adipocyte differentiationDiscovery of p1736, a novel antidiabetic compound that improves peripheral insulin sensitivity in mice modelsLack of an association between angiotensin receptor blocker based therapy and increased risk of cancer: evidence from large observational studiesMechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty ratsTranscription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells
P2860
Q24289202-4C1145DC-68B3-4E6E-A802-DF301699527FQ24315816-95EB3B05-0CBA-45FB-8DEF-F584F04EB5EDQ24322799-092CECD0-50FF-4916-846E-DEC74916EA9DQ24338255-D0D729F5-EFD1-4360-BA67-4744E310F0C9Q24523336-64E07129-F7A2-4244-94F6-6B73862601A7Q24533496-B48A93A4-7BEE-4D2D-A2C1-9C20D6015AB4Q24553023-126DA068-2CB1-41ED-BB4E-0507825F2FA6Q24553125-46244C5D-2A0D-413C-B1B2-761E53662B6CQ24617743-08C8BB86-5CFD-4034-8666-30FF2B6CF1E7Q24643006-D45CF8C0-4C8F-46A2-9CC4-FAE31458C91FQ24652863-66F1699D-B4CA-46F9-82DE-7C3DA66341D1Q24684054-BE33C1D6-F3CA-4F5D-826A-8F4766BB0D45Q24685818-ED145712-2D83-4703-B719-BAA3EF79A318Q26739350-315C7314-19B4-4048-882A-A75E2B351FEEQ26745520-8A573051-E73E-4ABD-A1E4-FB3052EB4260Q26750875-1E1D54AB-E58A-49F2-9539-E82728078A40Q26783337-E480D163-C5CA-46A6-970B-A33A090E3B16Q26783350-684BCEAC-AA56-4FDC-9A11-6138AC277458Q26784504-99941E6B-0A09-4797-B7A9-9DAAE53DC24AQ26863678-3F77DE69-B2FF-4158-8001-A4331623054EQ27303048-61315B90-97AB-4EC2-A46B-3D6AB68719DCQ27642784-4393929B-5AD5-4989-8979-77A7983B6380Q27647673-1B7DC967-AE7E-40E9-8424-AB590B99D1A5Q27704759-A82990BE-F2AF-4960-B50F-84B08A97724BQ27766012-C8A88C33-BC23-471B-9E14-774907F605BFQ28082790-351B6B9D-F387-46D3-88D9-8CFFED4C90D0Q28211498-453EE7E8-68AD-4586-B003-53E9577951B9Q28238709-32356EA5-BE0E-4906-BFA2-7D3389707F50Q28343733-E9B105CF-439E-4AC8-AF50-E270A329E5BEQ28360622-1BFB18A6-0AED-4E36-8E72-ADFF3A7576D7Q28370354-1B53E24F-B232-40D4-A7F9-35B2FFB931B2Q28377342-6E9EEA3C-8E90-480E-89F6-F16F8BE3F801Q28383025-3C2C081B-EC65-4DA1-B9CF-21FABAD7D1DCQ28484781-7C0E9D63-B0C6-443E-A8D4-C46CDE3C6012Q28508365-6E438CB5-2B43-4DE4-9549-3E6DECEA8C8AQ28510944-B0BA2002-2753-45D7-AD10-2D746950EC5CQ28534604-785D4E85-C23E-48E3-A7D3-23C75E40BFA3Q28544725-16E419D6-919E-4B98-A783-37148249204BQ28567397-0B23C3B9-B9E3-43A5-9694-BDA075F46C27Q28580328-8B6EF30F-4081-4104-996A-A339DE10BF6B
P2860
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
@en
type
label
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
@en
prefLabel
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
@en
P1433
P1476
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
@en
P2093
Spiegelman BM
P304
P356
10.2337/DIABETES.47.4.507
P407
P577
1998-04-01T00:00:00Z